Home Forums Melanoma Diagnosis: Stage IV Merck approval from FDA in 2015

  • This topic is empty.
Viewing 3 posts - 1 through 3 (of 3 total)
  • Author
    Posts
  • #21491
    jamesa
    Participant

    Hi Everyone,

    I was disappointed to read that Merck PD1 would not be getting approved till 2015! 😥

    In this article Merck is stating the following:

    “Merck said Sunday it plans to start late-stage clinical trials testing lambrolizumab in patients with a deadly form of skin cancer, melanoma, as well as non-small-cell lung cancer, in the third quarter. If all goes well, the company could file for regulatory approval in 2015.”

    Link to article:

    http://www.marketwatch.com/story/merck-drug-shrinks-tumors-in-melanoma-patients-2013-06-02

    #62034
    Catherine Poole
    Keymaster

    You never know, it could be sooner. But I will see what I can find out.

    #62035
    gostan
    Participant

    Unfortuntely, Merck is under huge investor pressure. They spend $8 billion on R&D but newly appointed head of R&D Roger Pearlmutter has had his budget cut and along with federal sequester cuts, this 2015 FDA approval date is more of a reality than just a PR spin. It really sucks for all of us, but there is not much we can do about thiis other than investing in Merck & BMS stocks in order to keep them investing in future cures.

Viewing 3 posts - 1 through 3 (of 3 total)
  • The forum ‘Melanoma Diagnosis: Stage IV’ is closed to new topics and replies.